HHS Logo U.S. Department of Health & Human Services Divider arrowNIH logo National Institutes of Health Alt desc
Skip Over Navigation Links
dropper and test tubes

Pfizer’s Centers for Therapeutic Innovation (CTI) for NIH Researchers

NCATS leads an innovative collaboration for the NIH with Pfizer’s Centers for Therapeutic Innovation (CTI) that is designed to help bridge the gap between early scientific discovery and its translation into new medicines through public-private resource-sharing. Learn more about the CTI.

Find NCATS Programs & InitiativesAccess NCATS Expertise & Resources

About Pfizer’s CTI for NIH

Scientific image

Read more about Pfizer’s CTI for NIH intramural researchers.

Areas of Interest

Scientific image

See the current therapeutic areas of interest for research proposals.

Call for Proposals

Scientific image

Find details about when calls for proposals occur and how to submit one.

    Joint Steering Committee

    Scientific image

    Learn about the role of the Joint Steering Committee and its members.

      Pfizer’s CTI for NIH Researchers

      Pfizer’s CTI pairs NIH intramural researchers with Pfizer scientists to pursue scientific and medical advances through joint research and development projects. The CTI model is the first NIH-wide biologics initiative with a pharmaceutical partner that NCATS coordinates on behalf of all NIH intramural researchers. The goal of the program is to identify biologic compounds with activity in a pathway or target of interest to an NIH intramural researcher and to Pfizer. Together, the scientific team works to move these compounds through laboratory testing and into clinical evaluation. Learn more about Pfizer’s CTI for NIH Researchers.